Navigation Links
Deodorants: Do we really need them?

New research shows that more than 75 per cent of people with a particular version of a gene don't produce under-arm odour but use deodorant anyway.

The study was based on a sample of 6,495 women who are part of the wider Children of the 90s study at the University of Bristol. The researchers found that about two per cent (117 out of 6,495) of mothers carry a rare version of a particular gene (ABCC11), which means they don't produce any under-arm odour.

While about 5 per cent of people who produce an odour do not use deodorant, more than a fifth (26 out of 117) of those who don't produce an odour do not use deodorant, a statistically highly significant difference. However, 78 per cent of people who do not produce odour, still use deodorant on all or most days.

Speaking about the novel finding, published today in the Journal of Investigative Dermatology, the lead author Professor Ian Day said:

'An important finding of this study relates to those individuals who, according to their genotype, do not produce under-arm odour. One quarter of these individuals must consciously or subconsciously recognise that they do not produce odour and do not use deodorant, whereas most odour producers do use deodorant. However, three quarters of those who do not produce an odour regularly use deodorants; we believe that these people simply follow socio-cultural norms. This contrasts with the situation in North East Asia, where most people do not need to use deodorant and they don't.'

The first author of the paper, Dr Santiago Rodriguez added:

'These findings have some potential for using genetics in the choice of personal hygiene products. A simple gene test might strengthen self-awareness and save some unnecessary purchases and chemical exposures for non-odour producers.'

The authors highlight that people who carry this rare genetic variant are also more likely to have dry (rather than sticky) ear wax and that checking ear wax is a good indicator of whether or not a person produces under-arm odour.

Previous studies have shown that there is a link between a genetic variant located in the ABCC11 gene and under-arm odour. Sweat glands produce sweat which, combined with bacteria, result in under-arm odour. The production of odour depends on the existence of an active ABCC11 gene. However, the ABCC11 gene is known to be inactive in some people.

This study looked for the first time at deodorant usage in relation to ABCC11 genotype and also in comparison with other factors such as age, background and general household hygiene. At the individual level, the influence of ABCC11 genotype was much stronger than the other factors. The statistical support for the ABCC11 finding was extremely strong the random chance of getting the same answer was less than one in a million million million odds.


Contact: Dara O'Hare
University of Bristol

Related biology news :

1. Thermodynamics really from scratch -- in a new textbook
2. What is really causing the child obesity epidemic?
3. Are we really a nation of animal lovers?
Post Your Comments:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology: